Gov. Gavin Newsom introduced Monday that California will stockpile an emergency provide of two million abortion drugs often called misoprostol in response to a federal decide in Texas ruling towards the authorization of one other remedy that has been used to terminate pregnancies for many years.
“In response to this extremist ban on a drugs abortion drug, our state has secured a stockpile of an alternate remedy abortion drug to make sure that Californians proceed to have entry to protected reproductive well being therapies,” Newsom mentioned in an announcement. “We won’t cave to extremists who’re attempting to outlaw these essential abortion companies. Medicine abortion stays authorized in California.”
The announcement follows U.S. District Choose Matthew Kacsmaryk’s ruling Friday that goals to nullify the federal Meals and Drug Administration’s approval of mifepristone, an abortion remedy that has helped hundreds of thousands of ladies to medically finish their early pregnancies.
Newsom mentioned the decide’s choice “ignores details, science, and the legislation” in a manner that places “the well being of hundreds of thousands of ladies and ladies in danger.”
“Abortion remains to be authorized and accessible right here in California and we gained’t stand by as elementary freedoms are stripped away,” he mentioned.
Mifepristone is used along with misoprostol as a standard abortion choice for girls in america, and analysis has proven the regime is protected and efficient. The 2-pill process will be substituted by a misoprostol-only choice, although that may be a much less efficient various.
Whereas the two-pill process remains to be most popular, Newsom’s workplace acknowledged, the state is within the course of of buying as much as 2 million misoprostol drugs because the presently accessible back-up choice to hold abortion simply accessible in California. Greater than 250,000 drugs have arrived within the state, in keeping with a Newsom administration assertion asserting the deal.
In the meantime, one other federal decide in Washington issued a separate ruling Friday that ordered the FDA to not make any modifications to the provision of mifepristone, organising a authorized battle anticipated to succeed in the US. Supreme Court docket.
